Combat & Casualty Care

Q2 2016

Military Magazines in the United States and Canada, Covering Combat and Casualty Care, first responders, rescue and medical products programs and news\Tactical Defense Media

Issue link: http://combatcasualtycare.epubxp.com/i/696867

Contents of this Issue

Navigation

Page 28 of 39

tacticaldefensemedia.com Combat & Casualty Care | Summer 2016 | 27 MedTech Medical App for POC Diagnostics In November 2015, Philips introduced Lumify, a smart device ultrasound that is transforming the way care is delivered and the way clinicians connect with their patients. With personalized ultrasound, clinicians now have easy access to ultrasound to enable quick decision making at the point of care, easing the patient experience and reducing healthcare costs. Philips' digital health approach to ultrasound allows clinicians to transform their compatible smart device into an advanced imaging solution, designed for fast point-of-care diagnostics, procedural guidance, data sharing and collaboration. Designed to help make ultrasound more accessible, Lumify operates on user-supplied compatible Android smart devices equipped with Internet and email functionality. To use Lumify, users download The Lumify App from Google Play, connect their Philips transducer to their compatible smart device via USB and launch the app to begin scanning. The Philips transducers available as part of the subscription support Lumify's use in acute and emergency care, internal medicine, musculoskeletal (e.g., orthopedics, sports medicine and podiatry) urgent care and office practice. Philips' advanced transducer technology, paired with cloud-enabled and tablet technology, helps users make fast, informed diagnoses through a variety of scan types. Lumify's scanning app allows users to examine the gall bladder, abdomen and lungs, in addition to having ob-gyn, vascular, superficial, musculoskeletal and soft tissue functionality. Beyond integrating with everyday technology such as personal, off-the-shelf, compatible smart devices, Lumify also uses cloud-enabled technology to connect with PACS, shared networks and system directories. Lumify is a solution that will grow with its users, with plans for regular software updates and additional transducers, services and apps being released at regular intervals. More info: janzcorporation.com Innovations in Regenerative Biomaterials MiMedx® is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. MiMedx is the leading supplier of amniotic tissue, having supplied over 600,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare. Since 2006, as the premier leader in regenerative medicine, MiMedx® has been dedicated to advancing healing through innovative biomaterial products and bioimplants. Our platform technologies include AmnioFix® and EpiFix® which are our tissue technologies processed from human amniotic membrane derived from donated placentas. Elected in advance of delivery through our donor program, a mother delivering a healthy baby via scheduled full-term Caesarean section birth may donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® Process to produce an easy to use and effective implant that can be stored at ambient conditions. The company's proprietary PURION Process and its multi- layer grafts are covered by over 20 issued patents, with more than 80 patents pending. AmnioFix and EpiFix allografts provide a scaffold for cellular ingrowth, modulate inflammation and reduce scar tissue formation for enhanced healing. To date, over 25 clinical and scientific papers have been published in peer-reviewed journals on the PURION Processed amniotic membrane allografts. More info: mimedx.com Special Pill for Special Ops During Navy Special Ops training, candidates complete exhaustive missions under extreme stress, limited sleep, and in freezing water conditions. For the last 25 years, the US military has used an ingestible thermometer pill to monitor the core body temperature of service members during physically demanding missions. CorTemp pill (HQ, Inc.) was developed in the mid-1980's by the Johns Hopkins Applied Physics Laboratory and the Goddard Space Flight Center. The sensor technology was first used on astronauts to detect hypothermia and hyperthermic conditions during space flight. Here is how the pill works: Soldiers swallow a 3/4-inch silicone-coated capsule which contains a microbattery and a quartz crystal temperature sensor. Within two hours, the quartz crystal sensor vibrates at a frequency relative to the body's temperature and transmits a harmless, low-frequency signal through the body. Team personnel can wirelessly monitor the core body temperature of multiple subjects in real time. There are several options and configurations for tracking temperatures, including the most simple method of holding the data recorder near the small of the back. The pill safely passes through the digestive system after 18 to 30 hours. The $50 pill is used at Special Warfare Combatant-craft Crewmen (SWCC) training facility in Coronado, Calif. where candidates swim in open sea ranging from frigid 48 degrees Fahrenheit to 72 degrees Farenheit. For SWCC personnel, the pill is used to monitor body core temperature and is used only in training. Its use ensures candidates can understand the impact of cold water and allows medical and training cadre staff to ensure safety parameters for training are observed. More info: scout.com Lumify MedTech MiMedx

Articles in this issue

Links on this page

Archives of this issue

view archives of Combat & Casualty Care - Q2 2016